scholarly journals Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Anja Lisa Riediger ◽  
Steffen Dietz ◽  
Uwe Schirmer ◽  
Michael Meister ◽  
Ingrid Heinzmann-Groth ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Mutation Analysis ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Plasma Dna ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Oncotarget ◽  
2016 ◽  
Vol 7 (11) ◽  
pp. 12404-12413 ◽  
Author(s):  
Shang-Gin Wu ◽  
Yi-Nan Liu ◽  
Meng-Feng Tsai ◽  
Yih-Leong Chang ◽  
Chong-Jen Yu ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Acquired Resistance ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document